{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T03:53:03Z","timestamp":1785815583350,"version":"3.56.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.euo.2025.12.009","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T12:15:30Z","timestamp":1767183330000},"page":"611-618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Quantifying the Impact of Biochemical Recurrence After Radical Prostatectomy on Overall Mortality by Years of Life Lost: Results from the SEARCH Database"],"prefix":"10.1016","volume":"9","author":[{"given":"Renning","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3043-0541","authenticated-orcid":false,"given":"Yuzhe","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Daskivich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher L.","family":"Amling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Aronson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Cooperberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda M.","family":"De Hoedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Guerrios-Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Klaassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha K.","family":"Terris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Luu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Freedland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2025.12.009_b0005","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.eururo.2015.04.035","article-title":"Patterns of clinical recurrence of node-positive prostate cancer and impact on long-term survival","volume":"68","author":"Nini","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.12.009_b0010","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.juro.2016.07.004","article-title":"Prognostic factors for biochemical recurrence more than 10 years after radical prostatectomy","volume":"197","author":"Liesenfeld","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.12.009_b0015","doi-asserted-by":"crossref","first-page":"175.e1","DOI":"10.1016\/j.urolonc.2024.02.010","article-title":"Contemporary risk of biochemical recurrence after radical prostatectomy in the active surveillance era","volume":"42","author":"Das","year":"2024","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2025.12.009_b0020","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.eururo.2011.02.026","article-title":"Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence","volume":"59","author":"Boorjian","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.12.009_b0025","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1001\/jama.281.17.1591","article-title":"Natural history of progression after PSA elevation following radical prostatectomy","volume":"281","author":"Pound","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.euo.2025.12.009_b0030","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.32900","article-title":"Biochemical recurrence and risk of mortality following radiotherapy or radical prostatectomy","volume":"6","author":"Falagario","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.euo.2025.12.009_b0035","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.eururo.2018.10.011","article-title":"Prognostic value of biochemical recurrence following treatment with curative intent for prostate cancer: a systematic review","volume":"75","author":"Van den Broeck","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.12.009_b0040","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0090-4295(99)00252-6","article-title":"Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year results","volume":"54","author":"Jhaveri","year":"1999","journal-title":"Urology"},{"key":"10.1016\/j.euo.2025.12.009_b0045","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/S0022-5347(17)32394-7","article-title":"The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy","volume":"152","author":"Trapasso","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.12.009_b0050","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/archinternmed.2010.262","article-title":"Impact of biochemical recurrence in prostate cancer among US veterans","volume":"170","author":"Uchio","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.euo.2025.12.009_b0055","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1002\/cncr.25013","article-title":"Impact of postoperative prostate-specific antigen disease recurrence and the use of salvage therapy on the risk of death","volume":"116","author":"Choueiri","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2025.12.009_b0060","doi-asserted-by":"crossref","first-page":"23240","DOI":"10.1093\/jnci\/djx179","article-title":"Understanding and communicating measures of treatment effect on survival: can we do better?","volume":"110","author":"Saad","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.euo.2025.12.009_b0065","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/JU.0000000000003892","article-title":"Salvage therapy for prostate cancer: AUA\/ASTRO\/SUO guideline part I: introduction and treatment decision-making at the time of suspected biochemical recurrence after radical prostatectomy","volume":"211","author":"Morgan","year":"2024","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.12.009_b0070","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jamasurg.2021.5803","article-title":"Patient preferences for communication of life expectancy in prostate cancer treatment consultations","volume":"157","author":"Daskivich","year":"2022","journal-title":"JAMA Surg"},{"key":"10.1016\/j.euo.2025.12.009_b0075","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1200\/JCO.2006.08.0572","article-title":"Death in patients with recurrent prostate cancer after radical prostatectomy: prostate-specific antigen doubling time subgroups and their associated contributions to all-cause mortality","volume":"25","author":"Freedland","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euo.2025.12.009_b0080","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.urology.2010.04.071","article-title":"Does PSADT after radical prostatectomy correlate with overall survival? \u2014 A report from the SEARCH Database Group","volume":"77","author":"Teeter","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.euo.2025.12.009_b0085","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1464-410X.2010.09878.x","article-title":"Long-term overall survival and metastasis-free survival for men with prostate-specific antigen-recurrent prostate cancer after prostatectomy: analysis of the Center for Prostate Disease Research national database","volume":"108","author":"Antonarakis","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2025.12.009_b0090","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1002\/cncr.23012","article-title":"Race, biochemical disease recurrence, and prostate\u2013specific antigen doubling time after radical prostatectomy","volume":"110","author":"Hamilton","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2025.12.009_b0095","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jclinepi.2003.12.008","article-title":"Time-dependent bias was common in survival analyses published in leading clinical journals","volume":"57","author":"van Walraven","year":"2004","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.euo.2025.12.009_b0100","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1001\/jama.294.4.433","article-title":"Risk of prostate cancer\u2013specific mortality following biochemical recurrence after radical prostatectomy","volume":"294","author":"Freedland","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.euo.2025.12.009_b0105","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/EDE.0b013e3181a819a1","article-title":"Overadjustment bias and unnecessary adjustment in epidemiologic studies","volume":"20","author":"Schisterman","year":"2009","journal-title":"Epidemiology"},{"key":"10.1016\/j.euo.2025.12.009_b0110","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jclinepi.2022.06.012","article-title":"Estimates of years of life lost depended on the method used: tutorial and comparative investigation","volume":"150","author":"Chudasama","year":"2022","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.euo.2025.12.009_b0115","doi-asserted-by":"crossref","unstructured":"Carstensen B, Plummer M. Epi: statistical analysis in epidemiology. Version 2.59. https:\/\/doi.org\/10.32614\/CRAN.package.Epi.","DOI":"10.32614\/CRAN.package.Epi"},{"key":"10.1016\/j.euo.2025.12.009_b0120","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1056\/NEJMoa2303974","article-title":"Improved outcomes with enzalutamide in biochemically recurrent prostate cancer","volume":"389","author":"Freedland","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euo.2025.12.009_b0125","doi-asserted-by":"crossref","unstructured":"Shore ND, Luz MDA, De Giorgi U, et al. Improved survival with enzalutamide in biochemically recurrent prostate cancer. N Engl J Med. In press. https:\/\/doi.org\/10.1056\/NEJMoa2510310.","DOI":"10.1056\/NEJMoa2510310"},{"key":"10.1016\/j.euo.2025.12.009_b0130","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN Guidelines\u00ae) prostate cancer version 2.2025. Plymouth Meeting, PA: NCCN; 2025."},{"key":"10.1016\/j.euo.2025.12.009_b0135","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.eururo.2024.04.010","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer. Part II\u20142024 update: treatment of relapsing and metastatic prostate cancer","volume":"86","author":"Tilki","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.12.009_b0140","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.juro.2008.01.040","article-title":"Limitations of prostate specific antigen doubling time following biochemical recurrence after radical prostatectomy: results from the SEARCH database","volume":"179","author":"Hamilton","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.12.009_b0145","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1111\/j.1464-410X.2009.08680.x","volume":"104","author":"Teeter","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2025.12.009_b0150","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13063","article-title":"Correlation between PSA kinetics and PSMA-PET in prostate cancer restaging: a meta-analysis","volume":"49","author":"Pereira Mestre","year":"2019","journal-title":"Eur J Clin Investig"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125003360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931125003360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T20:41:59Z","timestamp":1783197719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931125003360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2588931125003360"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2025.12.009","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantifying the Impact of Biochemical Recurrence After Radical Prostatectomy on Overall Mortality by Years of Life Lost: Results from the SEARCH Database","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2025.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}